Fundraising FoxCarcinotech
Scotland, GB · Incorporated in United Kingdom · 12 known investors
Find your way into Carcinotech
Sign up to see every warm intro you have to Carcinotech
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Carcinotech team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Carcinotech develops tumor models and assay solutions to improve preclinical drug development for cancer therapies. The company partners with drug developers to create biologically relevant models that accelerate cancer treatment development.
Founders & leadership
Investors · 12
How we know: Eos Advisory's portfolio page · scottish-enterprise-mediacentre.com · the VCSheet dataset · Not right? Tell us
How we know: scottish-enterprise-mediacentre.com · Not right? Tell us
How we know: scottish-enterprise-mediacentre.com · Not right? Tell us
How we know: scottish-enterprise-mediacentre.com · Not right? Tell us
How we know: scottish-enterprise-mediacentre.com · Not right? Tell us
Also in the syndicate · 3
Reported raises · per SEC filings
Form D private placements$508.5K disclosed across 1 round · 2023
▶$508.5KraisedJan 2024 · 1 investors · BiotechnologyRule 506(b)
- Albert NichollDirector
- Ishani MalhotraExecutive Officer, Director
- Ian David WaddellDirector
- Offering amount
- $508.5K
- Amount sold
- $508.5K
- First sale
- Dec 2023
- Incorporated
- Other, United Kingdom
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Companies House · registry record
View on Companies House ↗- Registered name
- CARCINOTECH LTD
- Company number
- SC604026
- Status
- Active
- Company type
- Private limited company
- Incorporated
- 31 Jul 2018
- Registered office
- Roslin Innovation Centre, Easter Bush Campus, Edinburgh, Midlothian, EH25 9RG
- Nature of business (SIC)
- 72110 — Research and experimental development on biotechnology
- Accounts
- last made up to 31 Dec 2025 · next due 30 Sept 2027
- Confirmation statement
- last made up to 30 Jul 2026 · next due 13 Aug 2027
Current officers · 4
- Mbm Secretarial Services Limited — corporate secretary, appointed 23 Jan 2023
- Lorna Ewart — director, appointed 4 Jun 2024
- Albert Nicholl — director, appointed 2 Oct 2020
- Ian David Waddell — director, appointed 3 May 2022
Source: Companies House public register · retrieved 1 Nov 2026. Contains public sector information licensed under the Open Government Licence v3.0.
In the news
Frequently asked questions
- What does Carcinotech do?
- Carcinotech develops tumor models and assay solutions to improve preclinical drug development for cancer therapies. The company partners with drug developers to create biologically relevant models that accelerate cancer treatment development.
- Who are Carcinotech's investors?
- Carcinotech's investors include Eos Advisory, Alba Equity, Gabriel Investment Syndicate, Investing Women Angels, Investment Fund for Scotland, Maven Capital Partners, Old College Capital, Scottish Enterprise and 1 more.
- How much funding has Carcinotech raised?
- Carcinotech has disclosed $508.5K raised across 1 round.
- Where is Carcinotech headquartered?
- Carcinotech is headquartered in Scotland, GB.